MYC amplification in angiosarcoma depends on etiological/clinical subgroups - Diagnostic and prognostic value

Affiliations

• ¹ Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pathology, 12 de Octubre University Hospital, Complutense University of Madrid, Investigation institute I+12, CIBERONC, Madrid, Spain.
• ² Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
• ³ Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands.
• ⁴ Department of Surgery, Radboud University Medical Center, Nijmegen, the Netherlands.
• ⁵ Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands.
• ⁶ Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands. Electronic address: Yvonne.Versleijen-Jonkers@radboudumc.nl.